Antibiotic Resistance: Page 2

Antibiotic susceptibility test in study reveals current antibiotics may cure superbugs

By Elissa Wolfson

The test revealed that some of the commercial, FDA-approved antibiotics can treat drug-resistant superbug infections.

May 1, 2023

Pattern Bioscience raises $28.7M in Series C financing to develop, commercialize rapid test platform for infectious diseases

By LabPulse.com staff writers

Pattern Bioscience said it will use the funds to complete the development of its infectious disease diagnostic platform, perform validation studies, and submit data for the platform and the company’s initial test for pneumonia for FDA review.

April 27, 2023

Fast, cheap method for detecting antimicrobial resistance could improve infectious disease care

By Nick Paul Taylor

Researchers at Ecole Polytechnique Fédérale de Lausanne in Switzerland have described a method for quickly determining if a pathogen is sensitive to an antibiotic using basic equipment.

April 25, 2023

FDA clears Selux Diagnostics gram-negative panel with AST system

By LabPulse.com staff writers

The Selux AST System is used for antimicrobial susceptibility testing, which determines whether an organism is susceptible or resistant to an antimicrobial drug.

April 21, 2023

Experts urge hospitals to establish C. difficile prevention programs in updated guidance

By Nick Paul Taylor

The updated guidance identifies diagnostic stewardship for the appropriate use and interpretation of C. difficile tests as an essential practice.

April 12, 2023

Beckman Coulter, MeMed collaborate to expand adoption of host immune response diagnostic test

By LabPulse.com staff writers

MeMed developed its BV test to address the management of patients with acute infection in different clinical settings, including emergency departments, and distinguish between bacterial and viral infections early in the diagnostic process.

January 31, 2023

Researchers find hidden bacteria that pose antimicrobial resistance risk to hospital patients

By Elissa Wolfson

Researchers have found that carriers of specific hidden bacteria have a 14% chance of developing an antibiotic-resistant infection within 30 days of hospitalization.

January 31, 2023

Day Zero awarded $8.2 million in CARB-X funding

By LabPulse.com staff writers

Day Zero is developing diagnostic tests that use genome sequencing and machine-learning algorithms to rapidly identify pathogens and their antibacterial-resistance profiles.

October 20, 2022

T2 Biosystems inks distribution agreement in Baltic region

By LabPulse.com staff writers

Under the terms of the agreement, the company will sell T2Dx Instruments, along with T2Bacteria, T2Candida, and T2Resistance panels, through an undisclosed distributor.

September 22, 2022

Guidance for antibiotics, diagnostics use in an epidemic

By Leo O'Connor

In a statement published Wednesday in Infection Control & Hospital Epidemiology, SHEA provided strategies for hospitals and healthcare personnel to improve antibiotic prescribing when they encounter new infectious disease outbreaks.

September 14, 2022

Method shown to rapidly identify children’s UTIs

By LabPulse.com staff writers

The method uses urinalysis results and other variables to predict UTIs and delivers answers before the two to three days needed for culture results.

July 26, 2022

Vela launches new PCR test for detecting urinary tract infection

By LabPulse.com staff writers

The test, called PathoKey MP UTI ID and AMR PCR, is currently for research use only, the company said. It allows for the in vitro detection and categorization of 14 pathogens that cause urinary tract infections and 14 antimicrobial resistance genes that block five antibiotics.

May 18, 2022

Previous Page

Page 2 of 4

Next Page